A few of India’s prime drugs manufacturers, which embody widespread ones comparable to Calpol, Allegra and Gelusil, might want to have QR or bar codes from August 2023.
In all, 300 manufacturers overlaying segments comparable to pain-killers, contraceptives, nutritional vitamins, blood-sugar and hypertension medicines, are included within the checklist.
Based on an order issued by the Centre on November 17, below the brand new Medication Guidelines or Medication (Eighth Modification) Guidelines, mentioning the bar codes of QR codes on the packaging will probably be necessary from August 1, 2023. The transfer has been initiated to assist confirm if the medicine are pretend or not.
“The producers of drug formulation merchandise as laid out in Schedule H2 shall print or affix Bar Code or Fast Response Code on its major bundle label, on secondary bundle label that retailer information and knowledge legible with software program software to facilitate authentication,” stated Union Well being Ministry notification.
A number of the different distinguished manufacturers which were included within the checklist are: Volini, Stamlo, T-Bact ointments, Montair and Fabiflu. Sources stated the manufacturers – thought-about to be high-selling ones – have been chosen primarily based on their transferring annual turnover (MAT).
The knowledge to be supplied embody distinctive product identification code, correct and generic title of the drug, model title, title and handle of the producer, batch quantity, date of producing, expiry date and manufacturing license quantity.
Comparable practices (of getting bar codes) are adopted in a few of the western nations that embody UK, the USA and others.